{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-006049","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2026-08-06T20:06:24+00:00","discovered_at":"2026-08-06T20:08:02.430271+00:00","generated_at":"2026-08-06T20:08:39.396889+00:00","sec_items":["1.01","8.01","3.02"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Valion Bio achieves first milestone under Statera license; issues preferred shares for $750K payment","bullets":["Achieved first milestone: validation of inventory for distribution and sales, triggering $750K payment.","Issued 1,287.8685 Series A Preferred shares to Statera and Avenue as partial consideration.","Milestone relates to Entolimod for Acute Radiation Syndrome (ARS) under A&R License Agreement.","Remaining ARS milestones total $1.75M; Neutropenia milestones up to $2.75M if option exercised.","Securities issued as unregistered, exempt under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-006049","json":"https://secwatch.observer/filing/0001683168-26-006049.json","markdown":"https://secwatch.observer/filing/0001683168-26-006049.md","text":"https://secwatch.observer/filing/0001683168-26-006049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/0001683168-26-006049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/valion_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:08:39.396889+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}